Feedback    Advertise    Submit Papers    Reprints    About    Help    Contact   
Upstream Processing Downstream Processing Manufacturing Analytical Facilities
Archive by Issue Archive by Article Type Supplements
CMC Forum Press Releases
Your Partner for High-Quality Protein Hydrolysates
Lorraine Niba
BioProcess International, Vol. 8, No. 7, July–August 2010, p. 14
 



FrieslandCampina Domo, a division of the Ingredients Business Group of Royal FrieslandCampina BV, is one of the operating companies formed as a result of the merger between Friesland Foods and Campina in January 2009 to form Royal FrieslandCampina. Royal FrieslandCampina is a leading global multinational company, with 22,000 employees and revenues of over 9 billion Euros.

Formerly Known As DMV International

The operating company FrieslandCampina Domo incorporates parts of the companies formerly known as DMV International Nutritionals and Friesland Foods domo. These entities have more than 75 years of experience in ingredient discovery, innovation, development, and marketing.

With a new name and enhanced capabilities, FrieslandCampina domo is expanding its presence in the global market. In addition to its global research and development and production facilities, the company recently opened new commercial headquarters for the Americas in northern New Jersey.

Quality, Productivity, Consistency, And Reliability

FrieslandCampina Domo is built on a legacy of more than 75 years of experience in product innovation, development, and production. With a foundation built on the three essential pillars of quality, innovation, and service, the company is a center of excellence for the development and production of protein hydrolysates.



FrieslandCampina Domo has state-of-the-art research and development facilities in Wageningen (the Netherlands) and Delhi (New York), as well as exemplary pilot-plant and manufacturing facilities at various other locations. FrieslandCampina Domo is one of the pioneering companies in the development of animal-free hydrolysates for use in biopharmaceutical media applications. The company's experts work in multidisciplinary teams that span research, process technology, and market knowledge, cognizant of topical issues of concern to customers such as raw-material supplier audits and QbD. FrieslandCampina Domo's technical expertise in hydrolysate research and innovation is the underpinning for its high-quality standards, consistency, and reliability.

A Portfolio of Hydrolysates For Cell Culture And Fermentation Applications

FrieslandCampina Domo offers a range of protein hydrolysates for media use in biopharmaceutical, cell culture, microbiological culture, and fermentation applications.

The company's product portfolio includes hydrolysates from various sources such as:

  • Soy protein hydrolysates

  • Cottonseed hydrolysate

  • Pea protein hydrolysate

  • Wheat gluten hydrolysate

These include options for ultra-filtered, kosher, non-GMO as well as other specifications that customers may desire.

Closer To You

FrieslandCampina Domo is a customer-focused company, committed to continuously improving its ability to engage customers and provide optimal service. The company offers valuable technical support and assistance, helping customers build success through mutual trust and collaboration.

Author Details
Lorraine Niba, PhD, is Marketing Manager–Americas at FrieslandCampina Domo, 61 S. Paramus Road, Ste 422, Paramus, NJ 07652; 201-655-7786; lorraine.niba@frieslandcampina.com..

 
| | Share
Biopharmaceutical Production
Facility Design Strategies for Single-Use Technologies

Please join us for a free webinar addressing strategies for facility design in biopharmaceutical manufacturing:

Wednesday, 29 February 2012
8:00 AM and 1:00 PM EST

Presented by:

Ingrid Long, MSc
Research Engineer
GE Healthcare Life Sciences

Register today!

During the webinar, Ms. Long will discuss the impact of different strategies for facility design, with a focus on the following topics:

* Replacement of traditional equipment with the single-use equivalent
* Biopharmaceutical manufacturing in a single room
* Benefits of facility design with respect to cost, risk, and flexibility

Register today!


Nine Conferences — One Location: Hilton Bayfront (San Diego, CA)
Webinars   
Subscribe   
Reprints   
Contact   
About   
Informa plc
©2002 - 2009 BioProcess International
Ph: 508-616-5550